Andrew Elphick

Andrew Elphick has extensive work experience in various leadership roles. In 1984, they began their career as a Sales and Marketing Manager at ICI, where they stayed until 2000. Andrew then became a Business Director at National Starch and Chemical from 2000 to 2004. From there, they joined Ernst and Young as a Chemical Sector Accounts Director in 2004, before transitioning to a Business Director role at Oxonica the same year. In 2006, they became the CEO of Iota NanoSolutions, serving until 2013. In 2014, they joined AJE-Technologies as the Managing Director. In 2016, Andrew Elphick became the CEO of Principal Medical Limited, a position they held until 2022. In 2022, they became the Chief Commercial Officer for Newrotex Ltd, and in 2023, they took on the role of Associate NED at Principal Medical Limited.

Andrew Elphick has a Bachelor's degree in Biology, General from the University of Nottingham. Andrew also holds a BSc degree in Biological Sciences from the same university. Additionally, Andrew has pursued an MBA degree in Business from the University of Birmingham. However, no specific start or end years are provided for any of these educational experiences.